Trial Profile
A Single Arm Pilot Study of Intrathecally Administered DepoCyt With Systemic Sorafenib in the Treatment of Neoplastic Meningitis From Solid Tumors.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Sorafenib (Primary)
- Indications Neoplastic meningitis
- Focus Adverse reactions
- 09 Aug 2011 Planned end date changed from 1 Sep 2016 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 09 Aug 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.